Table 6. The impact of characteristics on prognosis (discharge).

Candidate variables	*HR (95% CI)	P value
Age	1.00 (0.99, 1.00)	0.32
Gender
Female	Ref
Male	1.14 (0.84, 1.56)	0.41
Type
Mild / general	Ref
Severe / critical	0.78 (0.53, 1.15)	0.21
Comorbidities
Hypertension	0.94 (0.61, 1.44)	0.78
Chronic hepatobiliary disease	0.94 (0.48, 1.84)	0.86
Diabetes	0.96 (0.49, 1.87)	0.89
Heart disease (HD) (8 Coronary HD)	0.90 (0.42, 1.92)	0.78
Pulmonary diseases (1 COPD)	0.83 (0.34, 2.03)	0.69
Cerebrovascular disease	2.10 (0.98, 4.49)	0.06
Bone disease	0.89 (0.39, 2.01)	0.77
Gastric disease	0.63 (0.23, 1.72)	0.36
Gynecological (breast) disease (1 pregnancy)	2.27 (1.00, 5.15)	0.05
Other	1.12 (0.52, 2.38)	0.78
#Laboratory Indexes
White blood cell count	1.09 (0.94, 1.27)	0.24
Neutrophil count	1.04 (0.89, 1.22)	0.59
Lymphocyte count	1.07 (0.95, 1.22)	0.27
Eosinophil count	1.03 (0.91, 1.17)	0.60
Platelet count	1.07 (0.91, 1.25)	0.44
Hemoglobin	0.92 (0.79, 1.06)	0.24

Abbreviations: HR, hazard ratio; CI, confidence interval.

*HR values indicated the ratio of hazards of discharge among the patients with diverse antiviral therapy compared to the hazards of discharge among the patients with reference Lopinavir/Ritonavir alone treatment.

For ^#Laboratory Indexes, HR (95% CI) was calculated by using the hazards of discharge at 1 standard deviation (SD) increase of the laboratory indexes compared to the hazards of discharge at baseline laboratory indexes.